![Riad Sherif](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Riad Sherif
Directeur Général chez OCULIS HOLDING AG
Fortune : 10 M $ au 30/06/2024
Postes actifs de Riad Sherif
Sociétés | Poste | Début | Fin |
---|---|---|---|
REVENIO GROUP OYJ | Directeur/Membre du Conseil | 08/04/2022 | - |
Independent Dir/Board Member | 08/04/2022 | - | |
OCULIS HOLDING AG | Directeur/Membre du Conseil | 01/12/2017 | - |
Directeur Général | 01/12/2017 | - | |
Investor Relations Contact | 01/12/2017 | - | |
Oculis SA
![]() Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Directeur/Membre du Conseil | - | - |
Directeur Général | 01/01/2017 | - | |
XPND Medical SA | Président | 01/01/2016 | - |
Fondateur | 01/01/2016 | - |
Historique de carrière de Riad Sherif
Anciens postes connus de Riad Sherif
Sociétés | Poste | Début | Fin |
---|---|---|---|
EURO BIOT | Directeur/Membre du Conseil | 28/02/2023 | - |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Sanofi-Aventis Algérie SpA | Corporate Officer/Principal | - | - |
Alcon Finland OY | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Suisse | 5 |
Finlande | 3 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
REVENIO GROUP OYJ | Health Technology |
OCULIS HOLDING AG | Health Technology |
Entreprise privées | 6 |
---|---|
Oculis SA
![]() Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Alcon Finland OY | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Sanofi-Aventis Algérie SpA | |
European Biotech Acquisition Corp.
![]() European Biotech Acquisition Corp. Financial ConglomeratesFinance European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland. | Finance |
XPND Medical SA |
- Bourse
- Insiders
- Riad Sherif
- Expérience